Fast-track your journey from R&D to commercialization
In a complex, competitive, and fast-paced market, startups in biotechnology and pharmaceuticals face many challenges. USDM’s experienced professionals can help you navigate the regulatory landscape and achieve compliance.
Let’s plan your roadmap for success.
Preparing for Commercialization
Creating a plan for your organization’s research and development, operational standards, pricing and marketing, and vendor selection (and more!) can be difficult if you are a new or emerging company.
USDM has decades of experience helping startup life sciences companies to:
USDM's Commercialization QMS Framework
The USDM Commercialization QMS Framework is a top-down solution designed to reinforce your quality goals and objectives, and implement a governance structure that supports your operations and procedures and organizational roles and responsibilities.
This framework provides a strategic and comprehensive compliance roadmap and ensures that its implementation complements your existing QMS program and fills any gaps.
Our Commercialization QMS Framework complies with:
- U.S. Food and Drug Administration (FDA) cGMP regulations
- European Medicines Agency (EMA) regulations
- Health Canada requirements
- Japan's Pharmaceuticals and Medical Devices Agency regulations
- The United Kingdom's Medicines and Healthcare Products Regulatory Agency regulations
- And many other global regulatory authorities
We’re ready to work with your Quality Assurance and Regulatory Affairs teams and meet your goals for quality and compliance. We are experts at developing right-size, phase appropriate, pragmatic quality management, and IT compliance programs.
We Help Start-Up and Emerging Life Science Companies:
to learn more or read on to see our work in action.
Case Study: Rapid Deployment of Enterprise-Wide GxP Applications
Case Study: CSV Program and Application Validation in Less than 6 Weeks
Case Study: Veeva Vault Implementation to Maximize GxP Uses
Blog: SOPs 101 – A Best Practice Approach for Emerging Life Sciences Companies